Vir Biotechnology (VIR) Revenue (2018 - 2026)

Vir Biotechnology's Revenue history runs 9 years deep, the most recent figure standing at $29000.0 for Q1 2026.

• In Q1 2026, Revenue fell 99.04% year-over-year to $29000.0; the TTM figure through Mar 2026 stood at $65.6 million (up 214.24% YoY), while the FY2025 annual figure was $68.6 million, down 7.61% from the prior year.
• Revenue came in at $29000.0 for Q1 2026 at Vir Biotechnology, down from $64.1 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $1.2 billion in Q1 2022 to a low of $29000.0 in Q1 2026.
• A 5-year average of $113.0 million and a median of $12.4 million in 2024 frame the typical range for Revenue.
• Across the five-year window, Revenue surged 62271.41% in 2022 and sank 99.3% in 2023, its largest moves.
• Vir Biotechnology's Revenue stood at $49.4 million in 2022, then tumbled by 66.03% to $16.8 million in 2023, then slipped by 26.29% to $12.4 million in 2024, then jumped by 417.78% to $64.1 million in 2025, then plunged by 99.95% to $29000.0 in 2026.
• According to Business Quant data, Revenue over the past three periods registered $29000.0, $64.1 million, and $240000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison